Charles River Laboratories CRL Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's other accrued liabilities?
- Charles River Laboratories (CRL) reported other accrued liabilities of $226.14M in Q1 2026.
- How has Charles River Laboratories's other accrued liabilities changed year-over-year?
- Charles River Laboratories's other accrued liabilities increased by 6.9% year-over-year, from $211.47M to $226.14M.
- What is the long-term trend for Charles River Laboratories's other accrued liabilities?
- Over 5 years (2020 to 2025), Charles River Laboratories's other accrued liabilities has grown at a 16.7% compound annual growth rate (CAGR), from $102.48M to $222.16M.